161 related articles for article (PubMed ID: 10586439)
1. [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].
Marie I; Lévesque H; Dominique S; Hatron PY; Michon-Pasturel U; Remy-Jardin M; Courtois H
Rev Med Interne; 1999 Nov; 20(11):1004-16. PubMed ID: 10586439
[TBL] [Abstract][Full Text] [Related]
2. [Interstitial lung diseases in polymyositis and dermatomyositis].
Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
[TBL] [Abstract][Full Text] [Related]
3. Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.
Beretta L; Caronni M; Raimondi M; Ponti A; Viscuso T; Origgi L; Scorza R
Clin Rheumatol; 2007 Feb; 26(2):168-72. PubMed ID: 16614793
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
5. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
Sahhar J; Littlejohn G; Conron M
Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of alveolitis and interstitial lung disease in scleroderma.
Latsi PI; Wells AU
Curr Opin Rheumatol; 2003 Nov; 15(6):748-55. PubMed ID: 14569205
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
8. Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine.
Hider SL; Woodhead M; Taylor PM; Bruce IN
Clin Exp Rheumatol; 2006; 24(2):215. PubMed ID: 16762168
[No Abstract] [Full Text] [Related]
9. Assessments of pulmonary involvement in patients with systemic sclerosis.
Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.
Highland KB; Silver RM
Curr Rheumatol Rep; 2005 Apr; 7(2):135-41. PubMed ID: 15760593
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
[TBL] [Abstract][Full Text] [Related]
12. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary involvement in systemic sclerosis].
Ioanăş M
Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
[No Abstract] [Full Text] [Related]
14. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
[TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis].
Schinke S; Riemekasten G
Internist (Berl); 2019 Dec; 60(12):1251-1269. PubMed ID: 31754753
[TBL] [Abstract][Full Text] [Related]
16. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac and pulmonary involvement in scleroderma].
Launay D; Hachulla E
Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
Wells AU; Steen V; Valentini G
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
[TBL] [Abstract][Full Text] [Related]
20. A successful therapy with plasma exchange for interstitial pneumonia of progressive systemic sclerosis.
Tamura K; Akiyama J; Oono K; Kadowaki S; Shimada T
Intern Med; 1992 May; 31(5):649-54. PubMed ID: 1504429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
